Deletion of the RNA-editing enzyme ADAR1 causes regression of established chronic myelogenous leukemia in mice.

Deletion of the RNA-editing enzyme ADAR1 causes regression of established chronic myelogenous leukemia in mice.
复制标题

DOI:
10.1002/ijc.27851
复制
发表时间:
2013-04-15
影响因子:
6.4
通讯作者:
Wang, Qingde
Wang, Qingde
中科院分区:
医学1区
文献类型:
--
作者:
Steinman, Richard A.;Yang, Qiong;Gasparetto, Maura;Robinson, Lisa J.;Liu, Xiaoping;Lenzner, Diana E.;Hou, Jingzhou;Smith, Clayton;Wang, Qingde

文献摘要

参考文献

被引文献

相似文献

Patients with chronic myelogenous leukemia (CML) respond well to tyrosine kinase inhibitors (TKIs) of the Bcr-Abl oncoprotein. However, intolerance and resistance to these agents remains a challenge, and TKI’s are unable to eradicate rare leukemia-initiating cells. Leukemia treatment would benefit from a better understanding of molecular signals that are necessary for the survival of leukemia-initiating cells but dispensable for normal hematopoietic stem cells. Leukemia-initiating cells in CML can arise from myeloid progenitor cells, a population that we have reported in normal hematopoiesis to depend on the RNA-editing enzyme ADAR1 (adenosine deaminase acting on RNA-1). We now report that Bcr-Abl transformed leukemic cells were ADAR1-dependent in a conditional ADAR1 knockout mouse model. ADAR1 deletion reversed leukocytosis and splenomegaly, and preferentially depleted primitive Lin-Sca+Kit+ (LSK) leukemic cells but not LSK cells lacking the leukemic oncoprotein. ADAR1 deletion ultimately normalized the peripheral white blood count, eliminating leukemic cells as assessed by PCR. These results uncover a novel requirement for ADAR1 in myeloid leukemic cells and indicate that ADAR1 may comprise a new molecular target for CML-directed therapeutics.
DOI: 10.1093/hmg/ddp443
发表时间: 2009-12-15
影响因子: 3.5
作者:
Borchert GM;Gilmore BL;Spengler RM;Xing Y;Lanier W;Bhattacharya D;Davidson BL
通讯作者: Davidson BL
识别广泛的超编辑人类RNA。
DOI: 10.1371/journal.pgen.1002317
发表时间: 2011-10
期刊: PLoS genetics
影响因子: 4.5
作者:
Carmi S;Borukhov I;Levanon EY
通讯作者: Levanon EY
DOI: 10.1182/blood-2007-05-092056
发表时间: 2008-02-15
期刊: BLOOD
影响因子: 20.3
作者:
Konig, Heiko;Holyoake, Tessa L.;Bhatia, Ravi
通讯作者: Bhatia, Ravi
DOI: 10.1158/1535-7163.mct-08-0636
发表时间: 2009-01-01
影响因子: 5.7
作者:
Flanagan, James M.;Funes, Juan M.;Boshoff, Chris
通讯作者: Boshoff, Chris
DOI: 10.1084/jem.189.9.1399
发表时间: 1999-05-03
期刊: The Journal of experimental medicine
影响因子: --
作者:
Li S;Ilaria RL Jr;Million RP;Daley GQ;Van Etten RA
通讯作者: Van Etten RA